Position in AVXL
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$76,946
-$19,755 QoQ
Shares Held
29,709
-5.7% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 179 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHOREO, LLC holds $19,777,074 across 42 Biotechnology names. AVXL ranks #33 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,514 | $3,438,199 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,474 | $3,215,830 | |
| 3 | INCY |
Incyte Corp
|
7,759 | $879,560 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,770 | $833,853 | |
| 5 | ARGX |
Argenx SE
|
809 | $750,565 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
3,045 | $733,753 | |
| 7 | TWST |
Twist Bioscience Corp
|
6,969 | $716,970 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
27,134 | $686,490 |
All Filings in AVXL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $76,946 | 29,709 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $96,701 | 31,499 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $113,887 | 31,991 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $293,237 | 32,948 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $308,049 | 33,411 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $194,096 | 22,622 | Shares | Sole | 2025-05-06 | |
| No filing history on record for this holder in this stock. | ||||||